Literature DB >> 12838956

Are health technology assessments a reliable tool in th analysis of the clinical value of PET in oncology? Who audits the auditors?

Liselotte Højgaard.   

Abstract

Mesh：

Year:  2003        PMID： 12838956     DOI： 10.1007/s00259-003-1203-4

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  3 in total

Review 1.  Positron emission tomography: establishing priorities for health technology assessment.

Authors:  G Robert; R Milne
Journal:  Health Technol Assess       Date:  1999       Impact factor: 4.014

2.  Preoperative staging of non-small-cell lung cancer with positron-emission tomography.

Authors:  R M Pieterman; J W van Putten; J J Meuzelaar; E L Mooyaart; W Vaalburg; G H Koëter; V Fidler; J Pruim; H J Groen
Journal:  N Engl J Med       Date:  2000-07-27       Impact factor: 91.245

3.  Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial.

Authors:  Harm van Tinteren; Otto S Hoekstra; Egbert F Smit; Jan H A M van den Bergh; Ad J M Schreurs; Roland A L M Stallaert; Piet C M van Velthoven; Emile F I Comans; Fred W Diepenhorst; Paul Verboom; Johan C van Mourik; Pieter E Postmus; Maarten Boers; Gerrit J J Teule
Journal:  Lancet       Date:  2002-04-20       Impact factor: 79.321
  3 in total
  4 in total

1.  Do we need randomised trials to evaluate diagnostic procedures? For.

Authors:  H Van Tinteren; O S Hoekstra; M Boers
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-11-29       Impact factor: 9.236

2.  The need for Health Technology Assessments of PET.

Authors:  H Van Tinteren; O S Hoekstra; M Boers
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-07-31       Impact factor: 9.236

3.  Health technology assessment of PET in oncology: re Eur J Nucl Med Mol Imaging 2003; 30:637-641.

Authors:  Finn Børlum Kristensen; Elizabeth Adams; Eduardo Briones; Damian Coburn; Karen Facey; Niels Würgler Hansen; Jetty Hoeksema; Berit Mørland
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02       Impact factor: 9.236

4.  Potential benefits of using a toolkit developed to aid in the adaptation of HTA reports: a case study considering positron emission tomography (PET) and Hodgkin's disease.

Authors:  Sheila Turner; Neil Adams; Andrew Cook; Alison Price; Ruairidh Milne
Journal:  Health Res Policy Syst       Date:  2010-05-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.